Cancer Biomarkers Market Volume to Surge Through 2031: Mapping a US$ 83.9 Billion Future
The shift from reactive to proactive oncology is fundamentally a numbers game. As diagnostic accessibility improves and screening programs expand, the Cancer Biomarkers Market Volume representing the total number of…
